An interventional study of Repellent lotion and Repellent Wipe in Bites and Stings, sponsored by Louisiana State University Health Sciences Center in New Orleans. Status unknown at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-27.
Sponsored by Louisiana State University Health Sciences Center in New Orleans · Not applicable, Interventional, and Prevention
To determine the efficacy and duration of protection of two topically applied insect repellent products at preventing landing by mosquitos. The study will follow the EPA Product Performance Test Guidelines1. It is intended to test the products against natural populations of mosquito species of public health importance within the genera Aedes, Anopheles, and Culex, and to replace data from one site previously tested in Florida with data from a site in Louisiana with adequate landing pressure from target mosquito species of public health relevance.
A single-site field setting study using healthy volunteers to test two insect repellent product formulations (lotion, and wipe) against mosquitos.
Subjects will have repellent applied to one lower limb at a standardised dose rate to account for skin area. They will then expose this area only in a field site where mosquitos are recorded landing at a rate of 5 mosquitos per 5 minute or higher. The exposure period will last five minutes and all mosquitos landing on the exposed skin will be collected using an aspirator. 5 minute exposure periods will be repeated every half hour for 14 hours for the lotion and 13 hours for the wipe, or until median CPT can be established by more than half of subjects reaching treatment failure.
112 studies on the registry are indexed under Bites and Stings; 45 are open to participants now.
This study's planned enrollment of 20 is below the median of 60 across 89 interventional studies indexed under Bites and Stings.
Browse Bites and Stings studies →Louisiana State University Health Sciences Center in New Orleans is the lead sponsor of 70 studies on the registry; 12 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Consider themselves to be in good general health, and specifically:
Able to understand and comply with the study procedures, including:
Exclusion Criteria:
Receives a dose of repellent on the lower portion of the leg that is exposed
Other: Repellent lotion · Other: Repellent Wipe
Does not receive a dose of repellent, but subject to similar exposure period
lotion of the repellent active ingredient IR3535
Also known as: IR3535 Repellent in lotion format
wipe of the repellent active ingredient IR3535
Also known as: IR3535 Repellent in wipe format
Median Complete Protection Time
the time for each repellent product tested that shows efficacy against mosquito bites
Time frame: 14 hours
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Louisiana State University Health Sciences Center in New Orleans